G Medical Innovations (GMVDW) Competitors

$0.02

0.00 (0.00%)

(As of 07/26/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Trends

GMVDW vs. LBPSW, AEHAW, ANZUW, SUBL, CCF, FWRLX, JUPWW, MJID, STRCW, and IXUS

Should you be buying G Medical Innovations stock or one of its competitors? The main competitors of G Medical Innovations include 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Anzu Special Acquisition Corp I (ANZUW), BioLingus (Cayman) (SUBL), Chase (CCF), Fidelity Select Wireless (FWRLX), Jupiter Wellness (JUPWW), Majestic Ideal (MJID), Palladyne AI (STRCW), and iShares Core MSCI Total International Stock ETF (IXUS). These companies are all part of the "manufacturing" sector.

G Medical Innovations vs.

4D pharma (NASDAQ:LBPSW) and G Medical Innovations (NASDAQ:GMVDW) are both manufacturing companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation, institutional ownership and community ranking.

: Company Net Margins Return on Equity Return on Assets
4D pharma N/A N/A N/A
G Medical Innovations N/A N/A N/A
: 4D pharma and G Medical Innovations both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
4D pharma N/A N/A
G Medical Innovations N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
4D pharma $522K N/A N/A N/A N/A
G Medical Innovations $4.42M N/A N/A N/A N/A
: In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled 4D pharma'saverage media sentiment score.
Company Overall Sentiment
4D pharma Neutral
G Medical Innovations Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
4D pharma
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
G Medical Innovations
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Net Margins	Return on Equity	Return on Assets
4D pharma	N/A	N/A	N/A
G Medical Innovations	N/A	N/A	N/A

Company	Underperform	Outperform
4D pharma	N/A	N/A
G Medical Innovations	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
4D pharma	$522K	N/A	N/A	N/A	N/A
G Medical Innovations	$4.42M	N/A	N/A	N/A	N/A

Company	Overall Sentiment
4D pharma	Neutral
G Medical Innovations	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
4D pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

G Medical Innovations beats 4D pharma on 1 of the 1 factors compared between the two stocks.

Ad WealthPress

This TSLA short trade is on a nine win hot streak

Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.

But I can promise that you’ll see all the details for yourself here.

Get G Medical Innovations News Delivered to You Automatically

GMVDW vs. The Competition

Export to Excel

Metric	G Medical Innovations	Surgical Appliance & Supplies Manufacturing Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	N/A	N/A	$2.02B	$8.21B
Dividend Yield	N/A	N/A	2.62%	3.96%
P/E Ratio	N/A	N/A	23.42	18.13
Price / Sales	N/A	N/A	46.61	89.14
Price / Cash	N/A	N/A	0.52	34.11
Price / Book	N/A	N/A	0.88	4.51
Net Income	N/A	N/A	$17.90M	$216.29M
7 Day Performance	N/A	N/A	-0.25%	1.78%
1 Month Performance	N/A	N/A	0.77%	7.93%
1 Year Performance	N/A	N/A	4.97%	3.07%

G Medical Innovations Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LBPSW 4D pharma	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	$522,000.00	0.00	N/A
AEHAW Aesther Healthcare Acquisition	0 of 5 stars 0.00 / 5 stars	$0.05 flat	N/A	-80.9%	$0.00	N/A	0.00	2	Gap Up
ANZUW Anzu Special Acquisition Corp I	0 of 5 stars 0.00 / 5 stars	$0.06 flat	N/A	+20.0%	$0.00	N/A	0.00	2
SUBL BioLingus (Cayman)	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	N/A	High Trading Volume
CCF Chase	0 of 5 stars 0.00 / 5 stars	$127.49 flat	N/A	N/A	$0.00	N/A	0.00	680	High Trading Volume
FWRLX Fidelity Select Wireless	0 of 5 stars 0.00 / 5 stars	$12.62 -0.9%	N/A	N/A	$0.00	N/A	0.00	147,000	High Trading Volume
JUPWW Jupiter Wellness	0 of 5 stars 0.00 / 5 stars	$0.26 flat	N/A	+205.1%	$0.00	$5.96M	0.00	8
MJID Majestic Ideal	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	N/A	High Trading Volume
STRCW Palladyne AI	0 of 5 stars 0.00 / 5 stars	$0.03 flat	N/A	-19.2%	$0.00	N/A	0.00	70
IXUS iShares Core MSCI Total International Stock ETF	0 of 5 stars 0.00 / 5 stars	$69.15 +0.9%	N/A	+4.7%	$37.78B	N/A	13.97	147,000